Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Lacellate Solution - 250

Company

IT3 Medical LLC (DUNS: 079971231)

Effective Date

February 23, 2022

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Lactic acid(310 mg in 100 mL)

Sodium chloride(600 mg in 100 mL)

Potassium chloride(30 mg in 100 mL)

Calcium chloride(20 mg in 100 mL)

Products (1)

Lacellate Solution - 250

NDC Product Code

70529-025

Application Number

NDA016682

Marketing Category

NDA (C73594)

Route of Administration

INTRAVENOUS

Effective Date

June 6, 2018

Ingredients

Lactic acidActive

Code: TU7HW0W0QTClass: ACTIBQuantity: 310 mg in 100 mL

Sodium chlorideActive

Code: 451W47IQ8XClass: ACTIBQuantity: 600 mg in 100 mL

Potassium chlorideActive

Code: 660YQ98I10Class: ACTIMQuantity: 30 mg in 100 mL

Calcium chlorideActive

Code: M4I0D6VV5MClass: ACTIBQuantity: 20 mg in 100 mL

WATERInactive

Code: 059QF0KO0RClass: IACT

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy